Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Am J Nephrol. 2018 Mar 7;47(3):153–161. doi: 10.1159/000487856

FIGURE 2. Percent of Patients with Monthly Serum Phosphorus ≤ 5.5 mg/dL at Baseline and SO Follow-up.

FIGURE 2

Phosphate binder pills/day for patients with in-range serum phosphorus decreased from (9.7, 8.8, 9.0) at baseline to (3.9, 4.4, 4.2, 4.4, 4.5, 4.8) at SO follow-up